In cancer cells, SPL expression has been shown to be down-regulated in human prostate cancer cells [42] but up-regulated in ovarian cancer cells [43], which suggests that SPL expression levels may also depend on the cancer cell type. This evidence concerns the gene SGPL1 and ovarian cancer.